Stephany Foster Spahr - 07 Oct 2022 Form 4 Insider Report for ONCOSEC MEDICAL Inc

Role
Director
Signature
/s/ Stephany Foster Spahr
Issuer symbol
N/A
Transactions as of
07 Oct 2022
Net transactions value
$0
Form type
4
Filing time
12 Oct 2022, 15:49:42 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCS Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 07 Oct 2022 Common Stock 50,000 $0.4500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest in quarterly installments over a one year period commencing on the first completed calendar quarter after the date of grant.